Cargando…

Monitoring of iron status in patients with heart failure

The 2016 ESC/HFA heart failure (HF) guidelines emphasize the importance of identifying and treating iron deficiency (ID) in patients with HF. Iron deficiency can occur in half or more of HF sufferers, depending on age and the phase of the disease. Iron deficiency can be a cause of anaemia, but it is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jankowska, Ewa A, Tkaczyszyn, Michał, Drozd, Marcin, Ponikowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937508/ https://www.ncbi.nlm.nih.gov/pubmed/31908613 http://dx.doi.org/10.1093/eurheartj/suz231

Ejemplares similares

Drug therapy in elderly heart failure patients
por: Jankowska, Ewa A, et al.
Publicado: (2019)

Iron status, catabolic/anabolic balance, and skeletal muscle performance in men with heart failure with reduced ejection fraction
por: Tkaczyszyn, Michał, et al.
Publicado: (2021)

Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners
por: Drozd, Marcin, et al.
Publicado: (2016)

Iron Deficiency and Deranged Myocardial Energetics in Heart Failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2022)

Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2018)

Iron deficiency as an emerging therapeutic target in patients stabilized after an episode of acute heart failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2021)

Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
por: Tkaczyszyn, Michał, et al.
Publicado: (2023)

Iron Deficiency in Heart Failure: A Korea-Oriented Review
por: Jankowska, Ewa A., et al.
Publicado: (2023)

Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression
por: Kobak, Kamil A., et al.
Publicado: (2021)

Iron Status and Short-Term Recovery after Non-Severe Acute Myocarditis: A Prospective Observational Study
por: Franczuk, Paweł, et al.
Publicado: (2023)

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
por: Jankowska, Ewa A., et al.
Publicado: (2013)

Cardiovascular Complications of Viral Respiratory Infections and COVID-19
por: Franczuk, Paweł, et al.
Publicado: (2022)

Multidimensional Approach to Frailty
por: Wleklik, Marta, et al.
Publicado: (2020)

Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones
por: Josiak, Krystian, et al.
Publicado: (2014)

Structural and functional abnormalities in iron-depleted heart
por: Kobak, Kamil A, et al.
Publicado: (2018)

Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency
por: Butler, Javed, et al.
Publicado: (2022)

Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure
por: Nawrocka-Millward, Sylwia, et al.
Publicado: (2021)

Health locus of control and the sense of self-efficacy in patients with systolic heart failure: a pilot study
por: Rydlewska, Agnieszka, et al.
Publicado: (2013)

Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising AFFIRM‐AHF
por: McEwan, Phil, et al.
Publicado: (2021)

Patients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) – Polish population
por: Straburzyńska-Migaj, Ewa, et al.
Publicado: (2015)

Heart rate and blood pressure monitoring in heart failure
por: Ponikowski, Piotr, et al.
Publicado: (2019)

10 year trends in hospitalization rates due to heart failure and related in‐hospital mortality in Poland (2010–2019)
por: Sierpiński, Radosław, et al.
Publicado: (2020)

Comparison of left ventricular longitudinal systolic function parameters in the prediction of adverse outcome in heart failure with preserved ejection fraction
por: Gozdzik, Anna, et al.
Publicado: (2021)

Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients
por: Martin‐Malo, Alejandro, et al.
Publicado: (2019)

Iron limitation promotes the atrophy of skeletal myocytes, whereas iron supplementation prevents this process in the hypoxic conditions
por: Kobak, Kamil, et al.
Publicado: (2018)

Patterns of dyspnoea onset in patients with acute heart failure: clinical and prognostic implications
por: Sokolska, Justyna Maria, et al.
Publicado: (2018)

Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis
por: Filippatos, Gerasimos, et al.
Publicado: (2023)

Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial
por: Metra, Marco, et al.
Publicado: (2022)

Rationale and design of the AMULET study: A new Model of telemedical care in patients with heart failure
por: Krzesiński, Paweł, et al.
Publicado: (2021)

Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM‐HFpEF)
por: Linde, Cecilia, et al.
Publicado: (2022)

Distinct clinical phenotypes of congestion in acute heart failure: characteristics, treatment response, and outcomes
por: Sokolska, Justyna Maria, et al.
Publicado: (2020)

Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure
por: Rozentryt, Piotr, et al.
Publicado: (2015)

Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency
por: Anker, Stefan D., et al.
Publicado: (2022)

Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial
por: Rosano, Giuseppe, et al.
Publicado: (2023)

Frailty and the risk of all‐cause mortality and hospitalization in chronic heart failure: a meta‐analysis
por: Uchmanowicz, Izabella, et al.
Publicado: (2020)

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
por: van Veldhuisen, Dirk J., et al.
Publicado: (2017)

Elevated plasma endothelin‐1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure
por: Zymliński, Robert, et al.
Publicado: (2020)

Expression and Complex Formation of MMP9, MMP2, NGAL, and TIMP1 in Porcine Myocardium but Not in Skeletal Muscles in Male Pigs with Tachycardia-Induced Systolic Heart Failure
por: Kiczak, Liliana, et al.
Publicado: (2013)

Expression of Iron Metabolism Proteins in Patients with Chronic Heart Failure
por: Kozłowska, Bogna, et al.
Publicado: (2022)

Hemosiderin Accumulation in Liver Decreases Iron Availability in Tachycardia-Induced Porcine Congestive Heart Failure Model
por: Kasztura, Monika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_etev74frv21g9f161qd8cef5tc